Anti-ageing Market In-Depth Analysis, Growth Strategies and Comprehensive Forecast to 2031

Based on the aforementioned factors, the anti-aging products, services, and devices market is slated to expand at a moderate pace of over 5.20% CAGR during the assessment period of 2021 and 2031.

ESOMAR-certified consulting firm Future Market Insights has forecast the anti-aging products, services and devices market to reach a valuation of US$ 369.79 Bn over the forecast period of 2021 and 2031.

Growing demand for anti-wrinkle treatment and anti-cellulite treatment across the U.S., India, UK, and Germany have propelled the market growth.

Increasing demand for clinically-evidenced ingredients is boosting non-invasive anti-aging cosmetic procedures.

As per the FMI’s analysis, the anti-aging products, services, and devices market across the U.S. and the UK is anticipated to expand at an impressive rate during the forecast period.

Growing prevalence of skin disorders such as atopic dermatitis, melanoma and non-melanoma skin cancer will improve the adoption of anti-ageing treatment.

With rising awareness regarding skin care routine and growing urgency to have younger looking skin have amplified the sales of products rich with retinols, moisturizer and dermal fillers reducing wrinkle lines among women.

Another key factor responsible for growing revenues in the anti-ageing market is promotion and advertisements featuring celebrities to endorse the products and treatments.

As such, key players are adopting different strategies to boost their revenue generation, fueling the market growth.

Download a FREE Sample Copy of the Report @

https://www.futuremarketinsights.com/reports/sample/rep-gb-1661

Key Takeaways from FMI’s Anti-Ageing Products, Services and Devices Market Study

  • In terms of application, anti-wrinkle treatment is anticipated to be the largest segment in terms of revenue
  • Anti-cellulite treatment will witness robust growth owing to the increasing number of people undergoing this procedure across the U.S. and the UK
  • The U.S. is anticipated to register high demand, leading the North America market over the forecast period
  • The UK and France will witness steady growth owing to the increasing ageing population and rising prevalence of skin disorders in the region
  • Driven by increasing demand of anti-ageing products among ageing population, Germany recorded notable growth, accounting for 15% of global market share
  • India is anticipated to emerge as a lucrative market backed by the high demand of cellulite treatment and chemical peels in the country

Request a Complete TOC of this Report with figures @

https://www.futuremarketinsights.com/toc/rep-gb-1661

Anti-Ageing Products Services and Devices Market by CategoryBy Application:

  • Anti-Pigmentation Therapy
  • Anti-Cellulite Treatment
  • Anti-Wrinkle Treatment
  • Acne Management
  • Scar Treatment
  • Others

By Product Type:

  • Creams
  • Moisturizers
  • Retinols
  • Dermal Fillers
  • Botulinum Toxin
  • Chemical Peels
  • Cellulite Treatment
  • Non-Surgical Fat Reduction
  • Others

By Distribution Channel:

  • Dermatology Clinics
  • Hospitals, Pharmacies, Drugstores
  • Rejuvenation Centers
  • Others

By Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • China
  • Japan
  • Asia Pacific excluding Japan (APEJ)
  • Middle East & Africa (MEA)

Competitive Landscape

Prominent players in the market are focusing on strategic mergers and collaboration to expand their global footprint in the market.

New product launches coupled with increasing research & development activities for the development of advanced anti-ageing products & devices will also be one of the key strategy to enhance their customer base for market players.

For instance, in December 2020, Devonian Health Group, a global clinical stage botanical pharmaceutical corporation, announced the launch of R-Spinasome anti-ageing technology global sales and marketing partnerships.

Also, in January 2021, Aptar Beauty, announced the development of its first airless roll-on capsule for LightinDerm Skincare Device.

Contact Sales for Further Assistance in Purchasing this Report @

https://www.futuremarketinsights.com/checkout/1661

Explore FMI’s Extensive ongoing Coverage on Healthcare Domain:

About Future Market Insights (FMI) 

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

Antibodies Market Current and Future Trends, Leading Players, Industry Segments and Regional Forecast By 2031 | Says FMI Analyst

According to Future Market Insights, a leading market research and competitive intelligence provider, the antibodies market will grow at a 21x pace in upcoming decades, surpassing US$ 601.614 Billion by the end of 2031.

As per FMI studies, the leading players in the antibodies market include F. Hoffmann-La Roche Ltd., AbbVie Inc., Johnson & Johnson Services, Inc., Amgen Inc., and Bristol-Myers Squibb Company. These key players together account for 3 out of 4 sales of antibodies across the globe.

According to the reports of the National Stem Foundation (NSCF), about 4% of the global population is affected by some sort of autoimmune disease. The most common autoimmune diseases are diabetes, multiple sclerosis, Crohn’s disease, and rheumatoid arthritis. Due to these chronic diseases, the demand for antibodies market is estimated through the roof.

Request a Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1330

Key Insights

Antibodies are essential for treating medical conditions including autoimmune diseases, cancer, and several types of neurological diseases. Immunoglobulin (IG) is a type of antibody that is used for the prevention of lower respiratory tract infections and diseases caused by the vaccinia virus. Rising cases of viral infection will drive the demand for antibodies.

The prevalence of autoimmune diseases is on the rise, and they also have the potential to act as a host for multiple chronic ailments. Owing to these factors, the demand for antibodies is forecast to increase in upcoming years.

The COVID-19 pandemic boosted the demand for antibodies as patients suffering from COVID-19 were highly susceptible to contracting various other ailments and, in some cases, triggered autoimmune diseases in the patient.

Novel biosimilar antibody manufacturers are slashing their prices to compete with branded antibody manufacturers, especially in the European market. With the expiration of patents of renowned products, a boost in demand for biosimilar antibodies can be expected in upcoming years.

A reasonable hike in research and development activities among healthcare and pharmaceutical market leaders are working towards developing effective and economical antibodies and biosimilar antibodies, propelling growth in the market.

Parkinson’s and Sclerosis diseases are on the rise among older people which is a key factor fueling the demand for antibodies. There is an urgency to develop cheap and personalized medicines, novel and effective treatments, and advanced therapeutics in middle-income countries which is expected to positively influence the sales of antibodies.

The widespread application of antibodies in chronic disease treatment is accelerating which is predicted to create scope for market expansion in the near future.

Competitive Landscape

Novartis AG, F. Hoffmann-La Roche AG, Johnson & Johnson, Takeda Pharmaceutical Company Limited, Amgen Inc., Biogen Inc., Bristol-Myers Squibb Company, AbbVie Inc., Sanofi SA, Eli Lilly, and Co. are some of the key companies profiled in the full version of the report.

Future Market Insights (FMI) has found that market players are working towards developing new antibodies to treat cancer and other diseases. They are also researching to create long-acting antibody drugs to reduce healthcare costs.

In order to gain a competitive edge in the antibodies market, key players are developing oral and noninvasive treatments using antibodies to treat chronic ailments. Strategic mergers and acquisitions for portfolio expansion are in the cards as well.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-1330

More Insights into Antibodies Market

The United States is considered the dominant market in the North American region owing to modern healthcare infrastructural facilities and the presence of leading market players in the country. An increase in government funding and elevated purchasing power is expected to drive growth in the market.

The GCC countries led by Saudi Arabia are increasingly focusing on research and development on early diagnosis and screening of cancer to elevate the survival rate and chance of successful treatment. The contribution of antibodies is significant in this research. Hence, propelling growth in the market.

The development and production of antibodies are on a rise in China and are expected to surge significantly owing to increasing government investment in drugs and development coupled with growing awareness about various medical ailments like rheumatoid arthritis, cancer, and infections.

The Indian antibodies market is anticipated to grow at a rapid pace owing to rising cases of cancer and cardiovascular diseases along with the development of the healthcare system in the country. According to the reports of the Global Cancer Observatory, 1.322 million new cancer cases were registered in India in 2020, while 2.72 million people had cancer for 5 years. A surge in cancer patients will drive the demand for monoclonal antibodies for cancer treatment.

Key Segments Covered in Antibodies Market Study

By Disease Indication

  • Cardiovascular diseases
  • CNS disorders
  • Cancer
  • Autoimmune Disorders

By Product Type

  • Monoclonal antibodies
  • Polyclonal antibodies
  • Antibody-drug complexes (ADCs)

By End User

  • Hospitals
  • Long-term Care Facilities
  • Research institutes

By Region

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia Pacific excluding Japan
  • Japan
  • Middle East and Africa (MEA)

Ask an Analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-1330+

Explore Other Reports Links From Healthcare Market:

https://techplanet.today/post/medical-cleaning-devices-market-recent-trends-demand-dynamic-innovation-in-technology-insights-2032

About Future Market Insights (FMI) 

Future Market Insights (ESOMAR-certified market research organization and a member of the Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel, and End Use over the next 10 years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

India Static Compression Therapy Market Key Players, Applications, Outlook, SWOT Analysis And Forecasts By 2032

Strong demand from diabetics and the geriatric population will continue to drive the growth of the India static compression therapy market in 2016. Demand will also grow on account of rising incidence of venous ulcers and other vein diseases. Compression bandages will continue to outsell compression garments, with the former accounting for a revenue share of over 60% in 2015. Overall, the India static compression therapy market is anticipated to rake in US$ 112 Mn in revenues in 2016.

Retail pharmacies will remain the dominant distribution channel, accounting for over 62% revenue share of the market in 2016. Valued at US$ 63 Mn in 2015, the retail pharmacies distribution channel will grow at 7.4% in terms of revenues to reach US$ 67.6 Mn in revenues in 2016.

For more insights into the market, request a sample of this report@ https://www.futuremarketinsights.com/reports/sample/rep-in-1680 

Sales of compression therapy products and services are also growing through online channels. Online pharmacies are leveraging on offering doorstep delivery and competitive pricing to appeal to end-users. Sales through online pharmacies totalled US$ 39.9 Mn in 2015, and are expected to grow at 5.5% in 2016 to reach US$ 42.11 Mn.

Several players are anticipated to enter the India static compression therapy market, considering the steady growth that the market is currently experiencing. 3M Co., BSN Medical, Sigvaris AG, and Vissco Healthcare are some of the leading players in the India static compression therapy market.

The key players in the India static compression therapy market are focusing on establishing the distribution channels and creating awareness about the benefits of compression stocks among patients. Coban 2 Lite Compression Systems, Jobst, and Vissco Platinum are some of the well-known static compression therapy products available in the market.

Long-term Outlook: The long-term outlook on the India static compression therapy market is positive, with total revenues expected to increase at a CAGR of 7.2% during the forecast period 2015-2025.

For Information On The Research Approach Used In The Report, Ask Analyst @ https://www.futuremarketinsights.com/askus/rep-in-1680 

Key Segments Covered

By Product Type

  • Compression Bandages
  • Compression Garments
    • Upper Garments
    • Lower Garments

By Distribution Channel

  • Retail Pharmacies
  • Online Pharmacies

About Future Market Insights (FMI) 

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

Acetone Market to surpass US$ 10.24 Bn by 2031, Says FMI

The global acetone market is projected to reach a value of US$ 10248.6 Mn in 2031, with the market growing at an average CAGR of 4.9% from 2021 to 2031. The target market is expected to experience increasing demand from the electrical, pharmaceuticals, paints and coatings, and automotive industries which will drive the market growth during the forecast period.

As chemical acetone is commonly used in agricultural chemicals such as fungicides and insecticides. This is because it is a good solvent and serves as a carrier agent for the active ingredients. Likewise, it is employed in thinning polyester resin and dissolving two-part epoxies and superglue before they harden. It further assists in the cleaning of polyester resins and gel coats.

Acetone can also act as an effective means of clearing casting resin from the skin. It is utilized in the production of gravure and flexography packaging printing inks. As Acetone is the fastest-drying solvent, it also gains usage as a solvent in screen printing to strip lacquer and lacquer-adhered stencils from screen materials. It also acts as an ink thinner.

Request A Report Sample to Gain Comprehensive Insights @ https://www.futuremarketinsights.com/reports/sample/rep-gb-276

The evolution of various end-use industries including automotive, chemicals, and pharmaceuticals might bolster the target market demand. It will also amplify the demand of acetone which will assist in the production of polycarbonates.

As polycarbonate is extensively used in diverse automotive parts of a car such as windows, headlamps, sunroofs, taillights, and many others, it is likely to foster growth for the global acetone market. Acetone also helps in the production of methyl methacrylate which is used in auto-glazing and for exterior car coating, as it is weather-resistant and shields against scratches.

Moreover, the strong demand for polycarbonates in different developed and developing economies is expected to positively influence the growth of the acetone market during the projected period.

“Heightened demand from the advancing automobile, pharmaceutical, and chemical sectors will augment the global sales of the acetone market over the forecast period,” says an FMI analyst. 

Key Takeaways:

  • The introduction of plastic resins will strengthen market prospects.
  • Low acute toxicity and the highly flammable nature of acetone may hinder market growth.
  • China’s acetone market is expected to dominate the global space.
  • A strong presence of plastic producers in Germany will drive the regional acetone market growth.
  • Low purity grade acetone will hold the largest market share during the forecast period.
  • The chemical industry will continue to remain the largest end-user of the acetone market.

Competitive Landscape 

Ineos Phenol, Altivia Chemicals, Royal Dutch Shell PLC, Sasol Ltd, The Dow Chemical Company, Domo Chemicals GmbH, Formosa Chemical and Fibre Corporation, Cepsa Quimica, SABIC, Honeywell Research Chemicals, and Spectrum Chemical Mfg. Corp. among others are some of the major players in the acetone market profiled in the full version of the report.

Leading market players are focusing on product innovation, novel solutions, and technologies to enhance their market position. These businesses employ partnerships and collaboration strategies to gain a competitive edge.

Ask for Customization in the Report, Enquire Now @ https://www.futuremarketinsights.com/customization-available/rep-gb-276

More Insights into Acetone Market Report

In its latest report, FMI offers an unbiased analysis of the global acetone market, providing historical data from 2016 to 2020 and forecast statistics for 2021 to 2031.

To understand the global market potential, growth, and scope, the market is segmented on the basis of product grade (≥ 99.5%, <99.5%), application (solvent, MMA, BPA, MIBK, others), end user (chemicals (agricultural chemicals, paints & coatings, rubber processing, polymer & resin processing, adhesives, printing ink), pharmaceuticals, cosmetics & personal care), and region.

According to the latest FMI reports, based on segmentation, the chemical industry is expected to remain the leading end-user of the target market. In addition, the pharmaceutical industry is also anticipated to generate greater demand during this period. In terms of grade, the low purity grade will dominate the international marketplace.

Based on region, the acetone market in China will exhibit remarkable growth during 2021-2031. As the leading consumer and manufacturer of acetone, China will continue to dominate the global market space. An abundant supply of raw materials and heightened consumption of acetone as a solvent will drive the target market growth in this region. Apart from China, Brazil, India, and Germany are likely to present substantial growth during the forecast period.

About Future Market Insights (FMI)

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Unit No: 1602-006
Jumeirah Bay 2
Plot No: JLT-PH2-X2A
Jumeirah Lakes Towers
Dubai
United Arab Emirates
LinkedIn| Twitter| Blogs
For Sales Enquiries: sales@futuremarketinsights.com

Bromine Derivatives Market Is Expected to reach US$ 5.7 Bn by 2029

A new market research study by Future Market Insights on the global bromine derivatives market contains global industry analysis 2014–2021 and opportunity assessment 2022–2029. The report investigates the bromine derivatives market and provides critical insights for the forecast period of 2022-2029.

As per the findings of the report, the global industrial bromine derivatives market is anticipated to experience substantial growth over the forecast period due increasing adoption of bromine compounds in various applications, such as flame retardants, PTA synthesis, oil & gas drilling, and others.

The global industrial bromine derivatives market was valued at ~US$ 4 Bn in 2021 and is projected to increase at a CAGR of ~ 3.9% during the projected period of 2022 and 2029. This growth is significantly driven by the expansion of chemical, oil & gas, and other end-use industries of bromine based chemicals.

Get Sample PDF Brochure: https://www.futuremarketinsights.com/reports/sample/rep-gb-1923 

Significant progress in numerous industry verticals, especially construction and chemicals in developing countries have resulted into increased demand for bromine derivatives. In an attempt to align with the evolving environmental policies, manufacturers are tapping into R&D and innovation space, according to the FMI study.

Global Bromine Derivatives Market: Vendor Insights

The report signifies some of the prominent market players, who have established themselves as leaders in the global bromine derivatives market. Few examples of key players in the market are Israel Chemicals Limited, Tosoh Corporation, Lanxess AG, Tata Chemicals Limited, Albemarle Corporation, Tetra Technologies Inc., Mil-Spec Industries Corporation, Jordan Bromine Company, Hindustan Salts Limited, Neogen Chemicals Limited, DSL Chemicals (Shanghai) Co. Ltd., and Solaris ChemTech Industries Limited, among others. The global bromine derivatives market is considerably dominated by some key players holding major shares of the market. Tier-1 players are collaborating with regional/local companies to increase their bromine-based product portfolio, thus, gaining a competitive edge over their peers.

Alternative Usage of Bromine Compounds in Various Industrial Applications

The global bromine derivatives market has been segmented based on derivative, application, end-use, and regions such as North America, Latin America, Europe, South Asia, East Asia, Middle East & Africa, and Oceania.

  • Consumption of bromine and its derivatives in Asia and BRIC nations is expected to grow steadily due to the underlying growth in end-use industries, such as dye manufacturing, pharmaceuticals, and specialty chemicals, and the shift in the production of consumer electronics from the U.S. and Europe to Asia. Factors mentioned above are expected to position Asia (South & East) as a major lucrative market for players in the bromine derivatives market.
  • Bromine derivatives are used in almost all end-use industries, such as pharmaceuticals, automotive, electronics, and others. Bromine compounds, such as methyl bromide, are mostly used as pesticides in the agriculture sector, owing to its highly active nature even at low temperatures. Over the past few years, bromine is used as a biocide and disinfectant in drinking and wastewater treatment, and swimming pools, respectively.
  • With developing oil drilling technologies, the use of bromine-based drilling solutions, also called brine fluids, are gradually spreading across the U.S., U.K., South East Asia, Africa, Middle East, and others. This is estimated to pave way for the growth of the global bromine derivatives market.

Regional Insights: 

Growing stringency of government regulations on the usage of halogenated flame retardants in the U.S., Canada, and EU countries, is a factor expected to decrease the consumption of bromine in these geographies.

However, in developing nations, such as China and India, government policies are not that strict on the use of brominated flame retardants as compared to that in the U.S. and EU member countries.

Request Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-1923

Bromine Derivatives Market By Category

By Derivatives :

  • Sodium Bromide
  • Calcium Bromide
  • Zinc Bromide
  • TBBPA
  • DPDPE
  • Others

By Application :

  • Flame Retardants
  • Organic Intermediates
  • Oil & Gas Drilling
  • Biocides
  • PTA Synthesis
  • Others

By End Use :

  • Chemical
  • Construction
  • Oil & Gas
  • Pharmaceuticals
  • Electronics
  • Others

About Future Market Insights (FMI)

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Unit No: 1602-006
Jumeirah Bay 2
Plot No: JLT-PH2-X2A
Jumeirah Lakes Towers
Dubai
United Arab Emirates
LinkedIn| Twitter| Blogs
For Sales Enquiries: sales@futuremarketinsights.com

Pharmaceutical Filtration Market: Top Trends and industry overview to watch for in 2032

The global pharmaceutical filtration market is expected to enjoy a valuation of US$ 17.8 Bn by the end of 2022 and further expand at a CAGR of 8.7% to reach a valuation of ~US$ 41.0 Bn by 2032. According to the recent study, membrane filters segment by product is leading the market with a share of about 33.3% in 2021.

Active pharmaceutical ingredients are a key component of the pharmaceutical industry in the 21st century. Filters are essential in a number of cases during the course of API creation and are necessary in bioscience laboratory applications as well. An increased production of large biologics and molecules, nano fibre technological advancements, generic market growth, and regulatory guidelines for cleanroom pharmaceutical production are the main factors driving the pharmaceutical filtration market. Additional funds diverted towards R&D expenditure by major biopharmaceutical organizations also boost the profile of the pharmaceutical filtration market

  • Manufacturing has the major portion of the revenue share in the pharmaceutical filtration market by operation in 2017 and is likely to remain so throughout the duration of the forecast period. The manufacturing segment is expected to cross a value of more than US$ 9.3 billion by end 2022 making it imperative for companies to be present in this operation segment of the pharmaceutical filtration market. The pilot scale segment follows at a considerable distance but cannot be overlooked entirely in favour of manufacturing. The pilot scale filtration segment has strong scope in North America as the continent represents a little over a third of the pharmaceutical filtration market and is estimated to retain this share going forward
  • The cell separation segment comprises slightly above a sixth of the pharmaceutical filtration market by application and is predicted to lose popularity in the future. Nonetheless, the North America cell separation market alone is on track to push past a billion dollars by end 2022 and companies are advised to take this into account while devising their business strategies. The water purification segment has a similar revenue share to the cell separation segment in the pharmaceutical filtration market by application. After North America, the water purification segment is particularly prominent in Europe
  • In terms of technology, microfiltration is quite popular as it contributes nearly half the revenue share in the pharmaceutical filtration market in the year 2017. Furthermore, microfiltration is anticipated to witness a high CAGR of more than 5.5% for the period 2017-2022 ensuring that all key stakeholders have ample opportunity in this lucrative technology. Ultrafiltration is not as prominent as microfiltration in the pharmaceutical filtration market but is gaining traction recently. Ultrafiltration technology has the greatest scope in both North America and Europe as these two continents are projected to cross a billion dollars in terms of value by end 2022
  • North America is the largest region in the pharmaceutical filtration market and is poised to grow to more than US$ 6 billion by end 2022
  • The report has profiled a few of the companies in the pharmaceutical filtration market. These include The Marmon Group LLC, Sartorius Stedim Biotech, Meissner Filtration Products, Parker Hannifin Corporation, Pall Corporation, Merck KGaA, GE Healthcare Inc., Eaton Corporation Plc., Amazon Filters Ltd., and 3M Companies.

Request Sample PDF Brochure:

https://www.futuremarketinsights.com/reports/sample/rep-gb-5028

Key Segments:

Pharmaceutical Filtration Market Taxonomy

Region

  • North America
  • Latin America
  • Europe
  • Japan
  • APEJ
  • MEA

Product Type

  • Membrane Filters
  • Prefilters and Depth Media Filters
  • Single-use Systems
  • Cartridge & Capsule Filters
  • Filter Holders
  • Filtration Accessories
  • Other Products

Scale of Operation

  • Manufacturing Scale
  • Pilot Scale
  • R&D Scale
  • Application
  • Final Product Processing
  • Raw Material Filtration
  • Cell Separation
  • Water Purification
  • Air Purification

Technology

  • Microfiltration
  • Ultrafiltration
  • Nanofiltration
  • Other techniques

Get In Touch With Our Team For 20% Flat Discount:

https://www.futuremarketinsights.com/ask-question/rep-gb-5028

ABOUT FUTURE MARKET INSIGHTS, INC.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

Animal Healthcare Market: Top trends driving the industry to reach USD 54.5 Billion

The global animal healthcare market was estimated to be valued at US$ 42.3 Billion in 2021. The market is likely to grow at a CAGR of 4.3% through 2027, reaching US$ 54.5 Billion by 2027.

Along with animal health care, the rapid expansion of the animal feed additive market has also been witnessed with an expected compound annual growth rate (CAGR) of 4.6% through 2027, surpassing a valuation of around US$ 25.3 Bn, whereas, the production of animal segment, by animal type, is expected to grow at 4.7% CAGR, reaching around US$ 35 Bn by 2027.

Improved animal health is drastically becoming a top priority for people and governments across the world since they have a vital contribution to maintaining the balance of the ecosystem. Billions of dollars are being spent on vaccines, pharmaceuticals, and feed additives every year in order to protect animals from a wide range of diseases.

Key Takeaways

  • Surging demand for animal pharmaceuticals and vaccines will therefore continue to boost the growth of the animal healthcare market during the forecast period.
  • A huge variety of pharmaceuticals are being used to treat production and companion animals such as antibiotics, antiparasitics, anti-inflammatories, analgesics, and fertility drugs. Increasing awareness about animal care is set to spur growth in the animal healthcare market.
  • The rapid surge in animal healthcare product sales like pharmaceuticals is acting as a catalyst for the growth of the animal healthcare market and the trend is likely to continue in the future.
  • The increasing consumption of meat and dairy products, the rising prevalence of foodborne and zoonotic diseases, growing trend of pet adoption across the globe are some of the primary factors fueling demand in the animal healthcare market during the forecast period.
  • The account of rising pet adoption rates growing awareness about maintaining the proper health of animals, and surging demand for animal pharmaceuticals for enhancing the immunity system of animals over the last few decades have led to an increase in spending on animals significantly.
  • North America and Europe are projected to dominate the animal healthcare market, accounting for more than 60% of the market share and North America alone will command a market value of US$ 18.2 billion.

Competitive Landscape

Bayer AG, Cargill, Inc., Eli Lilly and Company, Boehringer Ingelheim GmbH, Ceva Sante Animale, Zoetis Inc., Merc & Co., Inc., Virbac S.A., and SeQuent Scientific Ltd. Etc. are some of the key companies profiled in the full version of the report.

Leading market players operating in the global animal healthcare market are constantly increasing in research and development for introducing new products at low costs. Besides this, they are adopting growth strategies such as partnerships, acquisitions, price reduction, and moving towards online platforms to expand tehri global footprint.

Request Sample Report:

https://www.futuremarketinsights.com/reports/sample/rep-gb-431

More Insights into the Animal Healthcare Market

The global animal healthcare market falls under the seven major regional segments such as North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan (APEJ), Japan, and Middle East & Africa (MEA).

North America is leading the global animal healthcare market, accounting for the maximum market share and the revenue is expected to reach US$ 18,186.4 Mn by 2027 end. The Western Europe market is expected to account for the second largest market value share during the forecast period.

With the rapid expansion of the pet care market and surging demand for animal pharmaceuticals, North America and Europe will collectively constitute more than 60% of the market share over the forecast period.

Asia Pacific region is expected to grow at a phenomenal pace during the forecast period owing to the rising adoption of pets, expansion of the animal feed additives market, and penetration of new veterinary healthcare market entrants in countries like India and China.

On the basis of animal type, the global animal healthcare market has been segmented into production animals and companion animals.

The production animals segment is projected to grow at the fastest CAGR over the forecast period, reaching around US$ 35,041.9 Mn by 2027 end. The companion animals segment, on the other hand, is projected to grow at a CAGR of 3.6% over the forecast period.

Increased focus on protecting both production and companion animals from lethal diseases will continue to push the animal healthcare product sales during the forecast period.

Market Segmentation

Based on Product Type:

  • Feed Additives
  • Pharmaceuticals
  • Vaccines

Based on Animal Type:

  • Production Animals
  • Companion Animals

Get In Touch With Our Team For 20% Flat Discount:

https://www.futuremarketinsights.com/ask-question/rep-gb-431

ABOUT FUTURE MARKET INSIGHTS, INC.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

Orthopaedic Bone Cement and Casting Materials Market to grow at a rate of 6.3% by 2032 | Get Customized Reports

The global orthopaedic bone cement and casting materials market is also likely to witness a few trends in the near future. Growing research and development activities in the field of orthopaedics and increasing use of casting materials to treat orthopaedic injuries are expected to increase in the next few years, impacting the global market for orthopaedic bone cement and casting materials significantly.

In a recent global market study, the analysts of Future Market Insights examined the various factors impacting revenue growth of the global orthopaedic bone cement and casting materials market. An increasing prevalence of orthopaedic disorders and patient preference towards quality treatment for a better lifestyle are primarily responsible for fuelling market demand for orthopaedic bone cement and casting materials. The global orthopaedic bone cement and casting materials market is expected to enjoy a valuation of US$ 2.7 Bn in 2022. Sales in the market are projected to expand at a CAGR of 6.3% over the forecast period (2022-2032). Demand in the market is expected to surge by 2.1x, surpassing a valuation of ~US$ 5.1 Bn by 2032.

Request Sample PDF Brochure:

https://www.futuremarketinsights.com/reports/sample/rep-gb-4825

Future Market Insights analysis reveals the various factors that are likely to boost the growth in adoption of orthopaedic bone cement and casting materials. A growing number of people suffering from bone diseases such as osteoporosis, an increasing number of sports injuries and accidents leading to fractures of the bone, and the availability of advanced treatment options for severe back pain are some of the factors likely to drive the market towards high revenue growth in the coming decade.

Global Orthopaedic Bone Cement and Casting Materials Market: Regional Analysis & Forecast

Future Market Insights has tracked the performance of the global orthopaedic bone cement and casting materials market across the key geographies of North America, Latin America, Western Europe, Eastern Europe, Japan, APEJ, and MEA. Unsurprisingly, North America is the dominant regional market with estimated revenues in excess of US$ 1,400 Mn by the end of 2027, witnessing a CAGR of 5.1%. The APEJ orthopaedic bone cement and casting materials market is estimated to be valued at almost US$ 940 Mn by the end of 2027, recording an impressive CAGR of 9.7% – the highest among all the regional markets. The Western Europe regional market is slated to register a CAGR of 7.1% during 2017 – 2027.

Global Orthopaedic Bone Cement and Casting Materials Market: Segmental Forecasts

Forecast by Product Type:

The global orthopaedic bone cement and casting materials market is segmented on the basis of product type into Bone Cement and Casting Materials. The Bone Cement segment is expected to be the most lucrative product type segment with an attractiveness index of 1.1 and a CAGR of 6.9% in terms of value.

Forecast by Application:

The global orthopaedic bone cement and casting materials market is segmented on the basis of application into Joint Arthroplasty, Trauma Cases, Sports Injury, Spine Surgeries, and Others. Joint Arthroplasty is the most lucrative segment by application and also the largest, estimated to reach a market valuation of US$ 1,458.6 Mn by the end of 2027, registering a CAGR of 7.3%.

Forecast by End User: 

The global orthopaedic bone cement and casting materials market is segmented on the basis of end user into Hospitals, Ambulatory Surgical Centres, and Orthopaedic Clinics. Hospitals is the largest end user segment, estimated to reach a market valuation of just under US$ 2000 Mn and witness a growth rate of 7.0% between 2017 and 2027.

Get In Touch With Our Team For 20% Flat Discount:

https://www.futuremarketinsights.com/ask-question/rep-gb-4825

Global Orthopaedic Bone Cement and Casting Materials Market: Competitive Landscape

  • DJO Global, Inc.,
  • Heraeus Holding,
  • Zimmer Biomet,
  • BeneCare Medical,
  • BSN medical,
  • Stryker,
  • 3M Health Care Ltd.,
  • DePuy Companies (Sub. Johnson & Johnson Services, Inc.),
  • Smith & Nephew Plc,
  • Exactech, Inc.,
  • Medtronic, Inc.,
  • Braun Melsungen AG,
  • Cook Medical,
  • SOMATEX® Medical Technologies GmbH,
  • TEKNIMED,
  • T-Tape Company B.V.,
  • Lohmann & Rauscher GmbH & Co. KG,
  • MIKA MEDICAL,
  • Össur,
  • Innovation Rehab LTD.

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-4825

ABOUT FUTURE MARKET INSIGHTS, INC.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

Cardiac Surgery Devices Market to be worth USD 2 Bn by 2027, Get Insights FMI

Global Industry Analysis 2012 – 2016 and Opportunity Assessment 2017 – 2027’ has studied the cardiac surgery devices market and expects it to record a CAGR of 3.7% and be worth over US$ 2 Bn by end 2027.

The perfusion disposables segment represents a considerably larger market opportunity than either catheters, beating heart surgery systems, or heart lung machines in the cardiac surgery devices market.

The perfusion disposables segment is predicted to be worth more than US$ 800 Mn in 2017 alone with oxygenators contributing the lion’s share of this.

By the end of the forecast period, the segment is on track to push past US$ 1.1 Bn, making it a particularly lucrative segment in the cardiac surgery devices market as its attractiveness index is 2.0.

A greater acceptance of heart lung machine tables is expected to benefit the adoption of perfusion disposables in the cardiac surgery devices market.

Nearly a third of all the global deaths can be attributed to cardiovascular diseases and it is the main cause of death in the U.S., responsible for 17% of national healthcare expenditure.

The American Heart Association estimates that 40% of the American people will suffer from cardiovascular ailments in 2030 and the direct cost of these would skyrocket to approx. US$ 820 Billion.

Request Sample PDF Brochure:

https://www.futuremarketinsights.com/reports/sample/rep-gb-4602

Well-developed Medical Infrastructure Makes North America Keep its Crown

North America has a world-class medical infrastructure coupled with a population that is rapidly ageing and suffering from cardiopulmonary disorders.

This combination all but ensures that the region is larger than both Western Europe and APEJ combined in the year 2017 with a value of just under US$ 555 Mn.

North America is on track to witness a CAGR of 4.1% for the period 2017-2027 that should see the market in the region touch US$ 830 Mn by end 2027.

Most new developments are centred in North America and its high acceptance of modern technology make it an extremely lucrative region in the global cardiac surgery devices market.

Minimally Invasive Surgery Gaining Traction in Cardiac Surgery Devices Market

Coronary artery bypass grafting is anticipated to be the largest contributor in the cardiac surgery devices market by procedure in 2017 and it is unlikely to cede this position anytime soon.

However, modern advancements in cardiopulmonary bypass techniques, surgical approaches and incisions have made minimally invasive surgery increasingly popular in recent times.

Minimally invasive surgery has the advantage of reduced surgical trauma and decreased pain and this is anticipated to propel the cardiac surgery devices market in the long term.

In terms of CAGR these two segments hold the top position in the global cardiac surgery devices market, with coronary artery bypass grafting recording a value CAGR of 3.5% and minimally invasive surgery registering a 4.1% CAGR in terms of revenue during the forecast period.

Focus on Hospitals over Ambulatory Surgical Centres in the Cardiac Surgery Devices Market

The hospitals segment is larger than the ambulatory surgical centres segment by end user in the cardiac surgery devices market and this trend is predicted to continue for the foreseeable future.

An attractiveness index of 1.1 and a market opportunity of almost US$ 1.2 Bn by 2027 end should make all major companies actively target the hospitals end user segment in the cardiac surgery devices market.

Company Dashboard

The companies actively involved in the global cardiac surgery devices market that have been profiled in the report include Biotronik, Braile Biomedica, Cook Medical Inc., Estech, Abiomed, Smith Medical, MicroPort Scientific Corporation, Edwards Lifesciences Corporation, Angiodynamics, Teleflex Incorporated, C. R. Bard, Inc, B. Braun Melsungen AG, Getinge-Maquet Germany Holding GmbH, Terumo Corporation, LivaNova PLC, Lepu Medical technology Co ltd., Boston Scientific Corporation, Medtronic, and Abbott Laboratories.

Get In Touch With Our Team For 20% Flat Discount:

https://www.futuremarketinsights.com/ask-question/rep-gb-4602

Important takeaways

The increasing preference for minimally invasive surgical procedures is one of the recent trends seen in the cardiac surgery devices market.

In the last decade, minimally invasive cardiothoracic surgery has grown by leaps and bounds mainly because of the reduced pain and surgical trauma after this procedure.

Even though coronary artery bypass grafting is much larger at present, key stakeholders are advised to focus on minimally invasive procedures as patients will almost certainly prefer this form of treatment.

In addition to this, the beating heart surgery system type could see widespread adoption in the days ahead.

Cardiac Surgery Devices Market Taxonomy

By Product:

  • Heart Lung Machine
  • Breathing Heart Surgery Systems
    • Stabilisers
    • Positioners
  • Catheters
    • Ablation Catheter
    • Drainage Catheter
  • Perfusion Disposables
    • Oxygenators
    • Centrifugal Pumps
    • Cardioplegia Delivery System

By End User:

  • Hospitals
  • Ambulatory Surgical Centres

By Procedure:

  • Coronary Artery Bypass Grafting
    • On pump CABG
    • Off pump CABG
  • Minimally Invasive Surgery

By Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • APEJ
  • Japan
  • MEA

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-4602

ABOUT FUTURE MARKET INSIGHTS, INC.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

Diabetic Macular Edema Market to cross USD 4.2 Bn by 2032 | FMI

The global diabetic macular edema market size is expected to reach a valuation of US$ 3.7 Bn by the end of 2022, and further expand at a CAGR of 1.2% from 2022 to 2032. The market is projected to reach a valuation of ~US$ 4.2 Bn by the end of 2032.

An Uptake of Intravitreal Implants by Patients to Drive Growth of the Market in North America

North America will remain dominant in the global diabetic macular edema market. An uptake of intravitreal implants by new as well as existing patients, who do not show any improvement post-treatment with intravitreal injections, is expected to sustain growth of the market in this region.

Although control of diabetes is a health priority in developed North American countries, such as the U.S., less attention is given to DME management, with diabetes-related caregivers tending to focus on treatment of diabetic complications. A major reason behind this is lack of effective treatment for DME in North America. In addition, an error exists between industry sponsored and independently run clinical trials. Most of the independent clinical trials for DME treatment lack long-term results pertaining to safety and efficacy of new combination therapies for DME. These factors are likely to inhibit growth of the market in North America.

Diabetic Macular Edema Market in Western Europe to Register the Highest CAGR through 2027

The diabetic macular edema market in Western Europe is expected to register a comparatively higher CAGR than other region segments through 2027. Pharmaceutical companies in this region are making substantial investments in research and development, new technologies, and infrastructure in order to capture a market share in the surging burden of eye diseases. This is expected to retain growth of the market in Western Europe.

However, patients in Western Europe resist the intake of intravitreal injections of anti-VEGF drugs, which leads to an instant increase in intraocular pressure causing severe pain in the head or eyes. This a major factor impeding growth of the diabetic macular edema market in Western Europe.

Request Sample Report:

https://www.futuremarketinsights.com/reports/sample/rep-gb-2697

Anti-VEGF will Remain Preferred Product in the Global Diabetic Macular Edema Market

Anti-VEGF will remain preferred product in the market, with sales estimated to expand at 1% CAGR through 2027. Eylea will continue to be the most lucrative anti-VEGF drug in the market. However, demand for corticosteroids will remain comparatively lower than anti-VEGF during the forecast period.

By product form, intravitreal injections will continue to be sought-after in the market, with sales poised to surpass US$ 4,000 Mn by 2027-end. Sales of intravitreal implants will register a comparatively higher CAGR than intravitreal injections through 2027.

Hospital pharmacy is estimated to remain the largest distribution channel in the market, as majority of countries across the globe dispense intravitreal injections and implants to outpatients by hospital pharmacies. Retail pharmacy, which mainly provides aliquots of off-label indications such as Avastin prescription, will register a comparatively low CAGR than hospital pharmacy in the market through 2027.

Key market players identified in FMI’s report include Novartis AG, Bayer AG, Allergan Plc., F. Hoffman-La Roche Ltd., Alimera Sciences Inc., Valeant Pharmaceuticals International, Inc. (Bausch & Lomb Inc.)

Get In Touch With Our Team For 20% Flat Discount:

https://www.futuremarketinsights.com/ask-question/rep-gb-2697

ABOUT FUTURE MARKET INSIGHTS, INC.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs